Newswise — WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development. This workshop is co-sponsored with the Product Quality Research Institute (PQRI) and International Pharmaceutical Federation (FIP).
WHAT: In partnership with PQRI and FIP, AAPS is pleased to present the workshop Challenges and Opportunities in Establishing Scientific and Regulatory Standards for Assuring Therapeutic Equivalence of Modified Release Products. This two-day event will discuss some of the challenges presented by the complexity of Modified Release (MR) dosage forms. The workshop will consist of talks by experts from the pharmaceutical industry, academia, and the U.S. Food and Drug Administration.
WHY: This workshop aims to convene pharmaceutical scientists from academia, industry and regulatory agencies to review advances and regulations related to MR dosage forms, examine current and emerging issues, and identify critical paths to establishing scientific and regulatory standards for ensuring therapeutic equivalence and therapeutic interchangeability of MR products. WHEN: October 1-2, 2009Sheraton Inner Harbor HotelBaltimore, MD, USA
RSS